Clinical Trial Update: Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the safety and immunogenicity of the 9-valent HPV vaccine in HIV-positive women; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Centre Hospitalier Universitaire Saint Pierre | Conditions: HPV - Anogenital Human Papilloma Virus Infection, HIV Infections | Phase 4 | Status: ACTIVE_NOT_RECRUITING